Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Akari Therapeutics plc, 2 years.
Akari Therapeutics plc
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 5, 2026 | Akari Therapeutics plc | Grant or award | +3,240 | $7.90 | $25,593 |
| Aug 18, 2026 | Akari Therapeutics plc | Grant or award | +9,072 | $7.90 | $71,660 |
| Mar 6, 2025 | Akari Therapeutics plc | Grant or award | +446,428 | $1.12 | $499,999 |
| Dec 2, 2024 | Akari Therapeutics plc | Grant or award | +419,286,000 | — | — |
| May 31, 2024 | Akari Therapeutics plc | Grant or award | +1,326,258,000 | — | — |
Questions about Raymond Prudo-Chlebosz
What boards is Raymond Prudo-Chlebosz on?
Raymond Prudo-Chlebosz sits on the board of Akari Therapeutics plc.
How long has Raymond Prudo-Chlebosz served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.